{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Butyrate&page=2", "query": { "intervention": "Butyrate", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Butyrate&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-12T07:30:15.513Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04705480", "title": "Pregabalin vs. Gabapentin on Reducing Opioid Usage", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Analgesics", "Gabapentin", "Injuries", "Narcotics", "Pain", "Trauma" ], "interventions": [ { "name": "Pregabalin 50mg", "type": "DRUG" }, { "name": "Gabapentin 300mg", "type": "DRUG" }, { "name": "Neither Pregabalin nor Gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CAMC Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 109, "start_date": "2021-04-12", "completion_date": "2024-12-13", "has_results": true, "last_update_posted_date": "2026-01-06", "last_synced_at": "2026-09-12T07:30:15.513Z", "location_count": 1, "location_summary": "Charleston, West Virginia", "locations": [ { "city": "Charleston", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04705480" }, { "nct_id": "NCT02219373", "title": "Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness Study", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pediatric Chronic Neuropathic Pain" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Oxcarbazepine", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "8 Years to 18 Years" }, "enrollment_count": 60, "start_date": "2026-06", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-03-05", "last_synced_at": "2026-09-12T07:30:15.513Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02219373" }, { "nct_id": "NCT06882772", "title": "Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Congenital Heart Disease (CHD)" ], "interventions": [ { "name": "2 mL SunButyrate-TG", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "4 mL SunButyrate-TG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Nebraska", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "3 Years", "sex": "ALL", "summary": "1 Month to 3 Years" }, "enrollment_count": 105, "start_date": "2026-03", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-02-24", "last_synced_at": "2026-09-12T07:30:15.513Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06882772" }, { "nct_id": "NCT00232141", "title": "Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV Infections", "Peripheral Neuropathy" ], "interventions": [ { "name": "pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 302, "start_date": "2005-10", "completion_date": "2007-11", "has_results": true, "last_update_posted_date": "2021-02-09", "last_synced_at": "2026-09-12T07:30:15.513Z", "location_count": 41, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 29 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00232141" }, { "nct_id": "NCT00644137", "title": "GABA (Gamma Amino Butyric Acid) Medication for Tobacco", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Nicotine Dependence" ], "interventions": [ { "name": "pregabalin", "type": "DRUG" }, { "name": "cigarettes", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 24, "start_date": "2007-08", "completion_date": "2010-02", "has_results": false, "last_update_posted_date": "2020-04-02", "last_synced_at": "2026-09-12T07:30:15.513Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00644137" }, { "nct_id": "NCT01332968", "title": "A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-Hodgkin's Lymphoma" ], "interventions": [ { "name": "Obinutuzumab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Bendamustine", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1401, "start_date": "2011-07-06", "completion_date": "2021-07-30", "has_results": true, "last_update_posted_date": "2022-08-11", "last_synced_at": "2026-09-12T07:30:15.513Z", "location_count": 12, "location_summary": "Springdale, Arkansas • Irvine, California • Post Falls, Idaho + 9 more", "locations": [ { "city": "Springdale", "state": "Arkansas" }, { "city": "Irvine", "state": "California" }, { "city": "Post Falls", "state": "Idaho" }, { "city": "Galesburg", "state": "Illinois" }, { "city": "Sioux City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01332968" }, { "nct_id": "NCT03872180", "title": "Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "CCND1 Positive", "Mantle Cell Lymphoma", "t(11;14) Positive" ], "interventions": [ { "name": "Bendamustine", "type": "DRUG" }, { "name": "Obinutuzumab", "type": "BIOLOGICAL" }, { "name": "Venetoclax", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2019-04-11", "completion_date": "2026-07-15", "has_results": true, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-09-12T07:30:15.513Z", "location_count": 3, "location_summary": "Atlanta, Georgia • Johns Creek, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Johns Creek", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03872180" }, { "nct_id": "NCT00022074", "title": "Gabapentin For the Control of Hot Flashes in Women With Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anxiety Disorder", "Breast Cancer", "Depression", "Hot Flashes" ], "interventions": [ { "name": "gabapentin", "type": "DRUG" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Gary Morrow", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "120 Years", "sex": "FEMALE", "summary": "Up to 120 Years · Female only" }, "enrollment_count": null, "start_date": "2001-07", "completion_date": "2005-06", "has_results": false, "last_update_posted_date": "2015-10-15", "last_synced_at": "2026-09-12T07:30:15.513Z", "location_count": 18, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 15 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Denver", "state": "Colorado" }, { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT00022074" }, { "nct_id": "NCT07777965", "title": "Abuse Potential of Oral Gabapentin in Healthy, Non-Drug-Dependent Individuals With Recreational Sedative Drug Use Experience", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Healthy Non-dependent, Recreational Sedative Users" ], "interventions": [ { "name": "Alprazolam (Xanax)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Gabapentin (Neurontin® (Registered Trademark))", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 44, "start_date": "2026-06-18", "completion_date": "2026-08-31", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-09-12T07:30:15.513Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07777965" }, { "nct_id": "NCT00351611", "title": "Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Epilepsies, Partial" ], "interventions": [ { "name": "Lyrica (pregabalin)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 187, "start_date": "2006-07-26", "completion_date": "2020-02-04", "has_results": true, "last_update_posted_date": "2021-04-13", "last_synced_at": "2026-09-12T07:30:15.513Z", "location_count": 103, "location_summary": "Mobile, Alabama • Northport, Alabama • Tuscaloosa, Alabama + 57 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00351611" } ] }